Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus
Neuroscience, 2005•Elsevier
Adenosine is a neuromodulator that controls neurotransmitter release through inhibitory A1
and facilitatory A2A receptors. Although both adenosine receptor-mediated inhibition and
facilitation of glutamate release have been observed, it is not clear whether both A1 and A2A
receptors are located in the same glutamatergic nerve terminal or whether they are located
on different populations of these terminals. Thus, we have tested if single pyramidal
glutamatergic neurons from the hippocampus simultaneously expressed A1 and A2A …
and facilitatory A2A receptors. Although both adenosine receptor-mediated inhibition and
facilitation of glutamate release have been observed, it is not clear whether both A1 and A2A
receptors are located in the same glutamatergic nerve terminal or whether they are located
on different populations of these terminals. Thus, we have tested if single pyramidal
glutamatergic neurons from the hippocampus simultaneously expressed A1 and A2A …
Adenosine is a neuromodulator that controls neurotransmitter release through inhibitory A1 and facilitatory A2A receptors. Although both adenosine receptor-mediated inhibition and facilitation of glutamate release have been observed, it is not clear whether both A1 and A2A receptors are located in the same glutamatergic nerve terminal or whether they are located on different populations of these terminals. Thus, we have tested if single pyramidal glutamatergic neurons from the hippocampus simultaneously expressed A1 and A2A receptor mRNA and if A1 and A2A receptors were co-localized in hippocampal glutamatergic nerve terminals. Single cell PCR analysis of visually identified pyramidal neurons revealed the simultaneous presence of A1 and A2A receptor mRNA in four out 16 pyramidal cells possessing glutamatergic markers but not GABAergic or astrocytic markers. Also, A1 and A2A receptor immunoreactivities were co-localized in 26±4% of nerve terminals labeled with antibodies against vesicular glutamate transporters type 1 or 2, i.e. glutamatergic nerve terminals. This indicates that glutamatergic neurons in the hippocampus co-express A1 and A2A receptors and that these two receptors are co-localized in a subset of glutamatergic nerve terminals.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果